AIFF Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
514.0K
+6.0%
485.0K
+17.7%
412.0K
+6.2%
388.0K
+29.8%
299.0K
Cost of Revenue
261.0K
-1.1%
264.0K
+14.8%
230.0K
-5.0%
242.0K
+868.0%
25.0K
Gross Profit
253.0K
+14.5%
221.0K
+21.4%
182.0K
+24.7%
146.0K
-46.7%
274.0K
Operating Expenses
2.2M
-0.2%
2.2M
-16.8%
2.7M
-4.2%
2.8M
+46.9%
1.9M
R&D
525.0K
+23.8%
424.0K
-7.0%
456.0K
+20.6%
378.0K
+12.5%
336.0K
SG&A
1.7M
-5.8%
1.8M
-15.1%
2.1M
-6.3%
2.3M
+44.5%
1.6M
Operating Income
-1974000
+1.8%
-2010000
+19.6%
-2501000
+5.8%
-2656000
-62.5%
-1634000
EBITDA
-1927000
+1.9%
-1965000
+16.4%
-2350000
+3.9%
-2446000
-53.7%
-1591000
Net Income
-1984000
+1.0%
-2004000
+19.2%
-2480000
+6.0%
-2639000
-44.0%
-1833000
EPS (Basic)
$-0.10
+23.1%
$-0.13
+35.0%
$-0.20
+0.0%
$-0.20
-42.9%
$-0.14
EPS (Diluted)
$-0.10
+23.1%
$-0.13
+35.0%
$-0.20
+0.0%
$-0.20
-42.9%
$-0.14
Shares (Diluted)
20.6M
+26.8%
16.2M
+18.9%
13.7M
+1.1%
13.5M
+6.5%
12.7M
Firefly Neuroscience (AIFF) โ€” Financials